Work with a healthcare professional to set goals and monitor treatment: Dose titration, labs, and symptom checks reduce risks like hypoglycemia, pancreatitis, and kidney issues
Similarly, the Step-1 extension trial featuring 327 participants treated with semaglutide for 68 weeks produced similar results
Medical Conditions That May Qualify You If your BMI is between 27-29.9, you may still qualify for GLP-1 medications if you have: Type 2 diabetes or prediabetes High blood pressure (hypertension) High cholesterol or dyslipidemia Sleep apnea Cardiovascular disease Metabolic syndrome Insulin resistance These conditions are often interconnected with weight, and GLP-1 for weight loss can help address multiple health concerns simultaneously
In conclusion, GLP-1 RAs appear to be an option for the management of DM in KT recipients
Also, berberine can make it easier to tolerate metformin with fewer metformin side effects